Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

Timothy L. Wiemken(Pfizer (United States)), Farid Khan(Pfizer (United States)), Laura Puzniak(Pfizer (United States)), Wan Yang(Columbia University), Jacob E. Simmering(University of Iowa), Philip M. Polgreen(University of Iowa), Jennifer L. Nguyen(Pfizer (United States)), Luis Jódar(Pfizer (United States)), John M. McLaughlin(Pfizer (United States))
Scientific Reports
March 8, 2023
Cited by 139Open Access
Full Text

Abstract

Determining whether SARS-CoV-2 exhibits seasonality like other respiratory viruses is critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal pattern using time series models. We used time series decomposition to extract the annual seasonal component of COVID-19 case, hospitalization, and mortality rates from March 2020 through December 2022 for the United States and Europe. Models were adjusted for a country-specific stringency index to account for confounding by various interventions. Despite year-round disease activity, we identified seasonal spikes in COVID-19 from approximately November through April for all outcomes and in all countries. Our results support employing annual preventative measures against SARS-CoV-2, such as administering seasonal booster vaccines in a similar timeframe as those in place for influenza. Whether certain high-risk individuals may need more than one COVID-19 vaccine booster dose each year will depend on factors like vaccine durability against severe illness and levels of year-round disease activity.


Related Papers

No related papers found

Powered by citation graph analysis